Based on this deal VIvus is eligible to receive upto $61 million in upfront payments, Regulatory and sales milestones.
Sentiment: Strong Buy
You are correct but try to look it again. The subject is british and the description is american.
Stock doubles on study patients enrollment completion. Oppenheimer will be so excited to hear that they may raise the price target to $500.
Sentiment: Strong Sell
with their neutral ratings to get into for a ride up on lower prices. e.g, SPWR, MYGN earnings and so on. They attack the good earnings company at open with negative comments and company stock starts trending up later in the day and onwards. Those who know the SPWR earnings can understand the manipulation exactly. BUT it does not matter, BIG FUNDS like this loot retail investors and later if SEC wakes up, gets their share through settlements. What a shame !!!
You are right, falling below $22 will open a new range window of 18 - 22. I will also help adding inventory at or below $18.
Please do not misunderstand me as I want this to go down if things are not good or clear.
Its shows everywhere but their website that they are reporting earnings today. They reported 2nd Qtr. earnings on August 06, 2013 @8am. I am scared now with my recent position take as such hideous companies are stock manipulators big time. Also message board is a piece of junk with paid pumpers and bashers. Let’s see…
Finnaly MACD crossed above the signal line, signaling that flat margins negative will be covered by recent upgrade. Looks good to be closed above $33 now.
Noted that since 10:20am MACD is below the signal line and has never touched it since then. Looked into the report now and found out the following abot the margins:
Gross margin in the quarter was recorded at 40%, almost flat compared with the year-ago quarter. Selling, general and administrative expenses increased 11% year over year in the quarter to $256 million. Adjusted operating margin in the quarter declined roughly 170 bps year over year to 10.2%.
Therefore, I am not positive on this one now to be closed above $33.
Makes sense but dont think so. Today's close will be guaranteed above $33 and may pass 52 week highs after tomorrow's open, could take rest then a while.....
More on the way before tomorrow open, $15 or less in works.
Despite terrible earnings, there was not much of an activity AHs after 4:30pm. MMs are playing with the price and are trying to keep it up due to ASB (Accelerated Stock Buyback) Program. This should atleast be trading close to its 52 week low of $31.22. This stock needs analysts downgrades to reflect the correct market price.
Cannacord this morning came up with a comment "But despite shares being down 5.5% this month, there's about to double that decline today. The lower income-core [rent-to-own] customer is not not particularly healthy". There comments can be viewed in Dow John news published at 6:43am.
Sentiment: Strong Sell
I took a short position in SNDK @63.43 yesterday. Second half day volume trend was downwards and day end with two red lines with more than 200k volume each. SNDK surprised the market with exceptional results. Such blown out earnings surprise with beating analysts outlook expectations for the next quarter was not a part of my learning exprerience. BUT I still decided to stick with what I learned and got away without loss @63.30 AH.